Lahav Gil

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Panakeia Technologies Ltd. is a company based in Cambridge, UK. The British company's mission is to make precision medicine accessible to patients and doctors worldwide, even in remote areas. Panakeia is revolutionizing biomarker testing by using AI to provide results in minutes instead of days or weeks, ultimately improving real-world treatment for patients. Additionally, the company runs an annual campaign to raise awareness about the impact of breast cancer. The company was founded in 2018 by Pahini Pandya and Pandu Raharja-Liu, with Pahini Pandya serving as the CEO since then.

Panakeia Technologies Ltd. is a company based in Cambridge, UK. The British company's mission is to make precision medicine accessible to patients and doctors worldwide, even in remote areas. Panakeia is revolutionizing biomarker testing by using AI to provide results in minutes instead of days or weeks, ultimately improving real-world treatment for patients. Additionally, the company runs an annual campaign to raise awareness about the impact of breast cancer. The company was founded in 2018 by Pahini Pandya and Pandu Raharja-Liu, with Pahini Pandya serving as the CEO since then.

Xor Labs Toronto develops medical devices for organ transplantation and diseased organ treatment.

Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada.

UX Data Sciences Corp. operates as a medical technology and data science company. It developes UX-centric products and systems solutions for improving, tracking and monitoring medication adherence. The company was founded by German Kavoun and is headquartered in Ottawa, Canada.

Amplify Capital Inc invests in companies located in the Canada. The fund targets companies operating in the fields of health, education and clean tech. It provides financing for seed and early stage capital requirements with investment size of less than $250000.

Part of Blippmedia LLC, Pulse Medica provides medical surveillance services. The private company is based in Kinnelon, NJ. Pulse Medica was acquired by Blippmedia LLC on May 26, 2011.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Panakeia Technologies Ltd. is a company based in Cambridge, UK. The British company's mission is to make precision medicine accessible to patients and doctors worldwide, even in remote areas. Panakeia is revolutionizing biomarker testing by using AI to provide results in minutes instead of days or weeks, ultimately improving real-world treatment for patients. Additionally, the company runs an annual campaign to raise awareness about the impact of breast cancer. The company was founded in 2018 by Pahini Pandya and Pandu Raharja-Liu, with Pahini Pandya serving as the CEO since then.

Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada.

Panakeia Technologies Ltd. is a company based in Cambridge, UK. The British company's mission is to make precision medicine accessible to patients and doctors worldwide, even in remote areas. Panakeia is revolutionizing biomarker testing by using AI to provide results in minutes instead of days or weeks, ultimately improving real-world treatment for patients. Additionally, the company runs an annual campaign to raise awareness about the impact of breast cancer. The company was founded in 2018 by Pahini Pandya and Pandu Raharja-Liu, with Pahini Pandya serving as the CEO since then.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.